Latest News and Press Releases

SAN JOSE, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- SynAgile Corporation (www.SynAgile.com) today announced positive results from its Phase 2 clinical trial of continuous levodopa-carbidopa (LD-CD)...

SAN DIEGO, CA, Oct. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that...

EAST HARTFORD, Conn., April 07, 2022 (GLOBE NEWSWIRE) -- Riverside Health & Rehabilitation Center now offers advanced programming for Parkinson's Disease patients. The program provides an...

ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug...

BOULDER, Colo., Nov. 19, 2021 (GLOBE NEWSWIRE) -- When Carrie Barry, founder of the Corner Boxing Club and former national amateur boxing champion, opened her gym in 2014 she had a vision. She...

The Corner Boxing Club Hosts 36 Contenders Uniting to Fight for 30+ NonprofitsSaturday, November 20, 2021, 6:30-10:00PMBoulder Theater, 2032 14th Street, Boulder, CO 80302. BOULDER, Colo., Nov. 03,...

WILSON, Wyo., Oct. 27, 2021 (GLOBE NEWSWIRE) -- SynAgile is pleased to announce treatment of the first patient with the DopaFuse Delivery System in the SCOL (Study of Continuous Oral Levodopa)...

Treatment with RT001 Results in Statistically Significant Improvements in Overall Survival and Progression Free Survival for INAD Patients as Compared to Control Benefits Supported by Totality of...

LOS ALTOS, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...

LOS ALTOS, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...